Prof. Yankuo Qiao | Finance | Best Researcher Award

Prof. Yankuo Qiao, The George B. Delaplaine Jr. School of Business, Hood College, United States

Yankuo Qiao is an Assistant Professor of Finance at Hood College’s George B. Delaplaine Jr. School of Business, where he began in August 2022. Prior to this, he held the position of Visiting Assistant Professor of Finance at Oakland University. His academic journey is marked by a strong focus on finance, having completed a Ph.D. in Management from Rutgers Business School, specializing in Finance and Economics. His research interests span corporate finance, governance, behavioral finance, and corporate social responsibility, among others. Dr. Qiao’s work has been presented at numerous prestigious conferences globally, such as the American Finance Association and the Western Economic Association. With a passion for teaching and mentoring, he imparts knowledge across various finance and management disciplines. His academic achievements and contributions continue to shape the next generation of business leaders while advancing research in finance.

Professional Profile

scopus

orcid

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Yankuo Qiao is a highly qualified candidate for the Research for Best Researcher Award. With a Ph.D. in Management from Rutgers Business School, Dr. Qiao has made notable contributions in finance and economics, particularly in corporate finance, governance, and corporate social responsibility. His academic journey is marked by a Dean’s Dissertation Fellowship, which reflects his scholarly excellence.

Education

Yankuo Qiao holds a Ph.D. in Management with a focus on Finance and Economics from Rutgers Business School, completed in May 2021. His dissertation, “Three Essays in Corporate Management and Firm Policy,” reflects his deep expertise in corporate finance, with a committee chaired by renowned professors Ivan Brick, Darius Palia, and others. His academic journey began with a B.Sc. in Economics from the School of Business, Shandong University in May 2014. He later pursued an M.Sc. in Quantitative Finance from Rutgers Business School, graduating in May 2016, further enhancing his skills in financial analysis, corporate governance, and investment strategies. His education, combined with his research, has given him a solid foundation for his teaching and professional career, particularly in areas such as corporate governance, behavioral finance, and international business.

Experience

Dr. Yankuo Qiao is currently serving as an Assistant Professor of Finance at Hood College, where he has been since August 2022. He previously held the role of Visiting Assistant Professor of Finance at Oakland University from August 2021 to July 2022. During his academic tenure, he has taught various finance and business-related courses, including Managerial Finance, Corporate Finance, and International Business, at both undergraduate and graduate levels. His expertise extends beyond teaching, as he is also actively involved in academic research and publishing, with a particular focus on corporate governance, corporate social responsibility, and behavioral finance. His teaching experience spans esteemed institutions like Rutgers Business School, where he served as a primary instructor for advanced finance courses. Dr. Qiao’s experience also includes organizing workshops, contributing to curriculum development, and mentoring students in research methodologies.

Awards and Honors

Throughout his academic career, Dr. Yankuo Qiao has garnered several accolades that reflect his dedication to excellence. Notably, he was awarded the prestigious Dean’s Dissertation Fellowship for Academic Excellence at Rutgers Business School during his Ph.D. studies. His dissertation work, recognized for its insightful contributions to corporate finance and firm policy, earned him further acclaim in his field. Additionally, Dr. Qiao’s research has been featured in top-tier conferences, such as the American Finance Association (AFA) Annual Meeting and the Financial Management Association Annual Meeting. His paper presentations have been well-received at notable venues like the Western Economic Association International, where his innovative research on corporate governance and behavioral finance continues to influence academia. He has also been invited to numerous seminars and conferences worldwide, showcasing his expertise and dedication to advancing financial research.

Research Focus

Dr. Yankuo Qiao’s research primarily revolves around corporate finance, governance, and social responsibility, with a keen interest in understanding how corporate decision-making affects firm performance. He explores the dynamics of corporate governance, particularly in how internal and external mechanisms influence a CEO’s investment cycle and decision-making. His research also delves into behavioral finance, examining the psychological factors that affect financial decisions, and corporate social responsibility, exploring its impact on firm value and sustainability. Additionally, Dr. Qiao applies machine learning techniques to financial analysis, investigating the implications of textual data in finance and accounting. His current projects include studies on hate crimes’ impact on analyst behaviors, CEO career experiences in China, and the nexus of top management teams’ structures with stock liquidity and valuation. His forward-looking research is presented at global conferences, contributing significantly to the fields of finance and governance.

Publuaction Top Notes

The Application in the Portfolio of China’s A-share Market with Fama-French Five-Factor Model and the Robust Median Covariance Matrix
- Citation: 9
Impact of Internal Governance on a CEO’s Investment Cycle
- Citation: 6
The impact of external business environment on corporate social responsibility: Theoretical implications and empirical evidence
- Citation: 3
CEO turnover, stakeholder management, and dynamics between corporate social responsibility and firm performance
- Citation: 2
Attunement theory, CEO’s cyclical influence on corporate social responsibility and firm value
- Citation: 2

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Education

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.

Publications top notes

Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪

Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬

Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️

Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪

Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺

Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪

TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬

Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺

Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉